Compare Heron Therapeutics Inc (HRTX) vs IAC/Interactivecorp (PPLI) Price & Performance

HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.

Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.

PPLI trades at $44.71, up 0.4% today, with a bullish technical signal from moving averages and oversold short-term RSI. Recent quarters show earnings misses, but revenue stabilized near $2.4B in 2025. The stock trades below book value (P/B 0.73) and carries a consensus price target of $55.40. News highlights potential MGM acquisition talks and Q2 2026 earnings call scheduled for August 4th.

Outlook is mixed: strong analyst buy ratings (64%) and undervaluation signals support upside, but persistent net losses and volatile cash flows pose risks. Investors should weigh the discount to NAV against execution challenges in achieving profitability.